SARS-CoV-2 (COVID-19) Envelope Antibody

Primary Antibodies

SARS-CoV-2 (COVID-19) Envelope antibody can be stored at 4˚ C up to one year. Antibodies should not be exposed to prolonged high temperatures.

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic corona virus E proteins, and also viral replication (3).

Trial Size, New

SARS-CoV-2 (COVID-19) Envelope Antibody is affinity chromatography purified via peptide column.

SARS-CoV-2 (COVID-19) Envelope Antibody is supplied in PBS containing 0.02% sodium azide.

Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (93%)

Polyclonal

Wuhan seafood market pneumonia virus

Optimal dilutions for each application to be determined by the researcher.